Medical Care Technologies (OTC PINK:MDCE) Advances Rigorous Multi-Phase Validation of AI Imaging Platform

Rhea-AI Summary

Medical Care Technologies (OTC PINK:MDCE) has expanded its advanced internal evaluation framework for its proprietary AI imaging platform. The company is deploying a more rigorous, multi-phase testing architecture to systematically assess technical performance, including quantitative image quality metrics, end-to-end workflow efficiency in varied clinical simulations, and longitudinal tracking accuracy across sequential imaging datasets.

The enhanced processes use structured benchmarking, iterative model refinement, and controlled validation cycles to reinforce the platform’s technical foundation as development progresses. According to Medical Care Technologies, these initiatives align with its commitment to technical credibility and complement revenue-generating subsidiaries Infinite Auctions and Real Game Used within its diversified operating structure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Company expands sophisticated internal evaluation protocols targeting image quality metrics, workflow efficiency, and longitudinal tracking performance.

MESA, AZ / ACCESS Newswire / July 23, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced the expansion of its advanced internal evaluation framework for its proprietary AI imaging platform platform.

The Company is implementing a more rigorous, multi-phase testing architecture designed to systematically assess critical technical performance indicators. Current evaluation protocols focus on quantitative image quality metrics, end-to-end workflow efficiency under varied clinical simulation conditions, and the accuracy and consistency of longitudinal tracking functionality across sequential imaging datasets.

These enhanced processes incorporate structured benchmarking, iterative model refinement, and controlled validation cycles intended to strengthen the technical foundation of the platform as development continues.

"We are applying a disciplined, data-driven approach to the evaluation of our AI vision systems," said Marshall Perkins, CEO of Medical Care Technologies. "By expanding our internal testing protocols around image quality, workflow performance, and longitudinal tracking, we are building greater technical depth and operational readiness into the platform."

The expanded evaluation framework reflects Medical Care Technologies' ongoing commitment to technical credibility and methodical development. These efforts complement the Company's diversified operating structure, which includes revenue-generating subsidiaries Infinite Auctions and Real Game Used.

Medical Care Technologies continues to advance its AI imaging capabilities while maintaining focus on both technology development and subsidiary performance.

About Medical Care Technologies Inc. Medical Care Technologies Inc. (OTC PINK:MDCE) is a diversified technology company focused on the development and commercialization of artificial intelligence-powered applications spanning health, wellness, nutrition, lifestyle, and enterprise imaging analysis solutions. The Company also owns subsidiaries Infinite Auctions and Real Game Used, which provide complementary revenue-generating operations. Visit: https://medicalcaretechnologies.com

Safe Harbor Statement This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations and assumptions, and actual results may differ materially due to various risks and uncertainties. The company undertakes no obligation to update these statements except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements.

Contact Information: Medical Care Technologies Inc. 1910 S. Stapley Drive, Suite 221, Mesa, AZ 85204 Phone: +1 (480) 645-0750 Email: info@medicalcaretechnologies.com Website: https://medicalcaretechnologies.com

SOURCE: Medical Care Technologies Inc.

View the original press release on ACCESS Newswire

FAQ

What validation steps is Medical Care Technologies (OTC PINK:MDCE) taking for its AI imaging platform in July 2026?

Medical Care Technologies is expanding a rigorous multi-phase testing architecture for its AI imaging platform. According to Medical Care Technologies, the framework evaluates quantitative image quality, workflow efficiency under clinical simulations, and longitudinal tracking accuracy using structured benchmarking, iterative model refinement, and controlled validation cycles.

How does Medical Care Technologies’ new evaluation framework improve its AI imaging platform MDCE?

The framework aims to strengthen the AI imaging platform’s technical foundation through systematic testing. According to Medical Care Technologies, it emphasizes quantitative image quality metrics, end-to-end workflow performance, and consistent longitudinal tracking across sequential imaging datasets, supported by structured benchmarking and iterative refinement processes.

What are the main performance metrics assessed in Medical Care Technologies’ AI imaging validation?

The company focuses on image quality, workflow efficiency, and longitudinal tracking performance. According to Medical Care Technologies, current protocols measure quantitative image quality, test end-to-end workflow under varied clinical simulation conditions, and evaluate accuracy and consistency in tracking changes across sequential imaging datasets.

How does the AI imaging platform initiative relate to Medical Care Technologies’ subsidiaries Infinite Auctions and Real Game Used?

The AI imaging development runs alongside revenue-generating operations from Infinite Auctions and Real Game Used. According to Medical Care Technologies, the expanded validation framework complements its diversified structure, balancing technology advancement with ongoing performance of these complementary subsidiaries.

What areas does Medical Care Technologies target with its AI-powered applications beyond imaging analysis?

Medical Care Technologies develops AI-powered applications across health, wellness, nutrition, lifestyle, and enterprise imaging analysis. According to Medical Care Technologies, this diversified focus supports a broader commercialization strategy while the AI imaging platform undergoes rigorous internal validation and refinement.

Why is longitudinal tracking important in Medical Care Technologies’ AI imaging platform MDCE?

Longitudinal tracking enables consistent analysis across sequential imaging datasets over time. According to Medical Care Technologies, its expanded framework specifically evaluates the accuracy and consistency of this functionality to improve technical depth and operational readiness of the AI imaging platform.